Altered expression of the costimulatory molecules CD80, CD86, CD152, PD-1 and ICOS on T-cells from paracoccidioidomycosis patients: Lack of correlation with T-cell hyporesponsiveness

Clinical Immunology

Volumn 129, Issue 2, 2008, Pages 341-349

  Cacere, Camila R ^a   Mendes Giannini, Maria J S ^b   Fontes, Cor J ^c   Kono, Adriana ^d   Duarte, Alberto J S ^a   Benard, Gil ^a,d  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c HOSPITAL UNIVERSITÁRIO JÚLIO MÜLLER   (Brazil)

^d Clinical Hospital   (Brazil)

Author keywords

Adaptive tolerance; Anergy; Costimulatory molecules; Immunosuppression; Paracoccidioidomycosis; T lymphocyte

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; MEMBRANE ANTIGEN; MEMBRANE PROTEIN; PD 1 ANTIGEN; PROTEIN ICOS; PROTEIN PD 1; T LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CANDIDA; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MONOCYTE; PARACOCCIDIOIDES BRASILIENSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SCHOOL CHILD; SOUTH AMERICAN BLASTOMYCOSIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; APOPTOSIS REGULATORY PROTEINS; CELLS, CULTURED; CHILD; HUMANS; LYMPHOCYTE ACTIVATION; MIDDLE AGED; MONOCYTES; PARACOCCIDIOIDOMYCOSIS; T-LYMPHOCYTES;

EID: 53949088448     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.07.008     Document Type: Article

References (48)

1. Benard G., and Franco M. Paracoccidioidomycosis. In: Merz W.G., and Hay R.J. (Eds). Topley Wilson's Medical Mycology. 10th ed. (2005), Hodder Arnold, London 541-555
2. Restrepo A., McEwen J.G., and Castañeda E. The habitat of Paracoccidiodes brasiliensis: how far from solving the riddle?. Med. Mycol. 39 (2001) 232-241
3. Franco M., Mendes R.P., Dillon N.L., and Mota N.G.S. Paracoccidioidomycosis, a recently proposed classification of its clinical forms. Rev. Soc. Bras. Med. Trop. 20 (1987) 129-132
4. Walker S.L., Pembroke A.C., Lucas S.B., and Vega-Lopez F. Paracoccidioidomycosis presenting in the U.K. Br. J. Dermatol. (2007 Dec 7)
5. Oliveira S.J., Mamoni R.L., Musatti C.C., Papaiordanou P.M., and Blotta M.H. Cytokines and lymphocyte proliferation in juvenile and adult forms of paracoccidioidomycosis, Comparison with infected and non-infected controls. Microbes Infect. 4 (2002) 139-144
6. Benard G., Mendes-Giannin M.J.S., Juvenale M., Shikanai-Yasuda M.A., and Duarte A.J.S. Immunosuppression in paracoccidioidomycosis, T cell hyporesponsiveness to two Paracoccidioides brasiliensis glycoproteins that elicit strong humoral immune response. J. Infect. Dis. 175 (1997) 1263-1267
7. Mota N.G.S., Rezkallah I.M.T., and Peraçoli M.T. et al: Correlation between cell-mediated immunity and clinical forms of paracoccidioidomycosis. Trans. R. Soc. Trop. Med. Hyg. 79 (1985) 765-771
8. Musatti C.C., Rezkallah M.T.E., and Mendes N.F. In vivo and in vitro evaluation of cell-mediated immunity in patients with paracoccidioidomycosis. Cell Immunol. 24 (1976) 365-378
9. Benard G., Hong M.A., Negro G.M.B.D., Batista L., Shikanai-Yasuda M.A., and Duarte A.J.S. Antigen-specific immunosuppression in paracoccidioidomycosis. Am. J. Trop. Med. Hyg. 54 (1996) 7-12
10. Greenwald R.J., Freeman G.J., and Sharpe A.H. The B7 family revisited. Annu. Rev. Immunol. 23 (2005) 515-548
11. Mendes-Giannini M.J.S., Moraes R.A., and Ricci T.A. Proteolytic activity of the 43,000 molecular weight antigen secreted by Paracoccidioides brasiliensis. Rev. Inst. Med. Trop. 32 (1990) 385
12. Cacere C.R., Romano C.C., Mendes Giannini M.J., Duarte A.J., and Benard G. The role of apoptosis in the antigen-specific T cell hyporesponsiveness of paracoccidioidomycosis patients. Clin. Immunol. 105 (2003) 215-222
13. Morton P.A., Fu X.T., Stewart J.A., Giacoletto K.S., White S.L., Leysath C.E., Evans R.J., Shieh J.J., and Karr R.W. J. Differential effects of CTLA-4 substitutions on the binding of human CD80 (B7-1) and CD86 (B7-2). J. Immunol. 156 (1996) 1047-1054
14. Campanelli A.P., Martins G.A., Souto J.P., Martinez R., and Silva J.S. Possible involvement of Fas-induced apoptosis and CTLA-4 engagement in the hypo-responsiveness induced by Paracoccidioides brasiliensis infection. J. Infect. Dis. 187 (2003) 1496-1505
15. Azuma M., Ito D., Yagita H., Okumura K., Phillips J.H., Lanier L.L., and Somoza C. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366 (1993) 76-79
16. Bashuda H., Kimikawa M., Seino K., Kato Y., Ono F., Shimizu A., Yagita H., Teraoka S., and Okumura K. Renal allograft rejection is prevented by adoptive transfer of anergic T cells in nonhuman primates. J. Clin. Invest. 115 (2005) 1896-1902
17. D'Souza M., Fontenot A.P., Mack D.G., Lozupone C., Dillon S., Meditz A., Wilson C.C., Connick E., and Palmer B.E. Programmed death 1 expression on HIV-specific CD4+T cells is driven by viral replication and associated with T cell dysfunction. J. Immunol. 179 (2007) 1979-1987
18. Sun Z.W., Qiu Y.H., and Shi Y.J. et al. Time courses of B7 family molecules expressed on activated T-cells and their biological significance. Cell Immunol. 236 (2005) 146-153
19. Merlo A., Saverino D., Tenca C., Grossi C.E., Bruno S., and Ciccone E. CD85/LIR-1/ILT2 and CD152 (cytotoxic T lymphocyte antigen 4) inhibitory molecules down-regulate the cytolytic activity of human CD4+T-cell clones specific for Mycobacterium tuberculosis. Infect. Immun. 69 (2001) 6022-6029
20. Murphy M.L., Cotterell S.E., Gorak P.M., Engwerda C.R., and Kaye P.M. Blockade of CTLA-4 enhances host resistance to the intracellular pathogen, Leishmania donovani. J. Immunol. 161 (1998) 4153-4160
21. Steel C., and Nutman T.B. CTLA-4 in filarial infections: implications for a role in diminished T cell reactivity. J. Immunol. 170 (2003) 1930-1938
22. Sharpe A.H., Wherry E.J., Ahmed R., and Freeman G.J. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol. 8 (2007) 239-245
23. Schlienger K., Uyemura K., Jullien D., Sieling P.A., Rea T.H., Linsley P.S., and Modlin R.L. B7-1, but not CD28, is crucial for the maintenance of the CD4+T cell responses in human leprosy. J. Immunol. 161 (1998) 2407-2413
24. Pietrella D., Perito S., Bistoni F., and Vecchiarelli A. Cytotoxic T lymphocyte antigen costimulation influences T-cell activation in response to Cryptococcus neoformans. Infect. Immun. 69 (2001) 1508-1514
25. Inobe M., and Schwartz R.H. CTLA-4 engagement acts as a brake on CD4+T cell proliferation and cytokine production but is not required for tuning T cell reactivity in adaptive tolerance. J. Immunol. 173 (2004) 7239-7248
26. Sotomayor E.M., Borrello I., Tubb E., Allison J.P., and Levitsky H.I. In vivo blockade of CTLA-4 enhances the priming of responsive T cells but fails to prevent the induction of tumor antigen-specific tolerance. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 11476-11481
27. Unterkircher C.S., Yazaki S.C., Shimizu M.T., Jorge A.O., and Camargo Z.P. Specific components found in circulating immune complexes (CIC) in paracoccidioidomycosis. J. Med. Vet. Mycol. 34 (1996) 273-277
28. Freitas-da-Silva G., and Roque-Barreira M.C. Antigenemia in paracoccidioidomycosis. J. Clin. Microbiol. 30 (1992) 381-385
29. Sugizaki M.F., Peraçoli M.T., Mendes-Giannini M.J., Soares A.M., Kurokawa C.S., Mendes R.P., Marques S.A., and Freire-Maia D.V. Correlation between antigenemia of Paracoccidioides brasiliensis and inhibiting effects of plasma in patients with paracoccidioidomycosis. Med. Mycol. 37 (1999) 277-284
30. Chemnitz J.M., Parry R.V., Nichols K.E., June C.H., and Riley J.L. SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation. J. Immunol. 173 (2004) 945-954
31. Liang S.C., Latchman Y.E., Buhlmann J.E., Tomczak M.F., Horwitz B.H., Freeman G.J., and Sharpe A.H. Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur. J. Immunol. 33 (2003) 2706-2716
32. Trautmann L., Janbazian L., Chomont N., Said E.A., Gimmig S., Bessette B., Boulassel M.R., Delwart E., Sepulveda H., Balderas R.S., Routy J.P., Haddad E.K., and Sekaly R.P. Upregulation of PD-1 expression on HIV-specific CD8+T cells leads to reversible immune dysfunction. Nat. Med. 12 (2006) 1198-1202
33. Day C.L., Kaufmann D.E., Kiepiela P., Brown J.A., Moodley E.S., Reddy S., Mackey E.W., Miller J.D., Leslie A.J., DePierres C., Mncube Z., Duraiswamy J., Zhu B., Eichbaum Q., Altfeld M., Wherry E.J., Coovadia H.M., Goulder P.J., Klenerman P., Ahmed R., and Freeman G.J. Walker BD. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443 (2006) 350-354
34. Miyahira Y., Akiba H., Ogawa S.H., Ishi T., Watanabe S., Kobayashi S., Takeuchi T., Aoki T., Tezuka K., Abe R., Okumura K., Yagita H., and Watanabe N. Involvement of ICOS-B7RP-1 costimulatory pathway in the regulation of immune responses to Leishmania major and Nippostrongylus brasiliensis infections. Immunol. Lett. 89 (2003) 193-199
35. Rutitzky L.I., Ozkaynak E., Rottman J.B., and Stadecker M.J. Disruption of the ICOS-B7RP-1 costimulatory pathway leads to enhanced hepatic immunopathology and increased gamma interferon production by CD4 T cells in murine schistosomiasis. Infect. Immun. 71 (2003) 4040-4044
36. Benard G., Romano C., Cacere C.R., Juvenale M., Mendes-Giannini M.J.S., and Duarte A.J.S. Imbalance of IL-2, IFN-gamma and IL-10 secretion in the immunosuppression associated with human paracoccidioidomycosis. Cytokine 13 (2001) 248-252
37. Peraçoli M.T., Kurokawa C.S., Calvi S.A., Mendes R.P., Pereira P.C., Marques S.A., and Soares A.M. Production of pro- and anti-inflammatory cytokines by monocytes from patients with paracoccidioidomycosis. Microbes Infect. 5 (2003) 8-13
38. De Almeida M.C., Cardoso S.A., and Barral-Netto M. Leishmania (Leishmania) chagasi infection alters the expression of cell adhesion and costimulatory molecules on human monocyte and macrophage. Int. J. Parasitol. 33 (2003) 153-162
39. Kumar A., Angel J.B., Aucoin S., Creery W.D., Daftarian M.P., Cameron D.W., Filion L., and Diaz-Mitoma F. Dysregulation of B7.2 (CD86) expression on monocytes of HIV-infected individuals is associated with altered production of IL-2. Clin. Exp. Immunol. 117 (1999) 84-91
40. Agrewala J.N., Kumar B., and Vohra H. Potential role of B7-1 and CD28 molecules in immunosuppression in leprosy. Clin. Exp. Immunol. 111 (1998) 56-63
41. Bozzi A., Reis B.S., Prado F.L.S., Pedroso E.P., Leite M.F., and Góes A.M. Modulation of CD28 and CD86 expression in patients with paracoccidioidomycosis in different periods of treatment. Scand. J. Immunol. 60 (2004) 500-505
42. Mamoni R.L., and Blotta M.H.S.L. Kinetics of citokines and chemokines gene expression distinguishes Paracoccidioides brasiliensis infection from disease. Cytokine 32 (2005) 20-29
43. von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6 (2005) 338-344
44. Taylor P.A., Lees C.J., Fournier S., Allison J.P., Sharpe A.H., and Blazar B.R. B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions. J. Immunol. 5 (2004) 172-178
45. Greenfield E.A., Howard E., Paradis T., Nguyen K., Benazzo F., McLean P., Höllsberg P., Davis G., Hafler D.A., Sharpe A.H., and Freeman G.J. V.K. Kuchroo. B7.2 expressed by T cells does not induce CD28-mediated costimulatory activity but retains CTLA4 binding: implications for induction of antitumor immunity to T cell tumors. J. Immunol. 158 (1997) 2025-2034
46. Vahlenkamp T.W., Bull M.E., Dow J.L., Collisson E.W., Winslow B.J., Phadke A.P., Tompkins W.A., and Tompkins M.B. B7+CTLA4+T cells engage in T-T cell interactions that mediate apoptosis: a model for lentivirus-induced T cell depletion. Vet. Immunol. Immunopathol. 98 (2004) 203-214
47. Hayashi N., Liu D., Min B., Ben-Sasson S.Z., and Paul W.E. Antigen challenge leads to in vivo activation and elimination of highly polarized TH1 memory T cells. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 6187-6191
48. Chiodetti L., Choi S., Barber D.L., and Schwartz R.H. Adaptive tolerance and clonal anergy are distinct biochemical states. J. Immunol. 176 (2006) 2279-2291